These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 9839525

  • 1. Adenoviral expression of the cyclin-dependent kinase inhibitor p27Kip1: a strategy for breast cancer gene therapy.
    Rakkar AN, Li Z, Katayose Y, Kim M, Cowan KH, Seth P.
    J Natl Cancer Inst; 1998 Dec 02; 90(23):1836-8. PubMed ID: 9839525
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis.
    Le XF, Vallian S, Mu ZM, Hung MC, Chang KS.
    Oncogene; 1998 Apr 09; 16(14):1839-49. PubMed ID: 9583681
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M, Muller WJ, Singh G, Graham FL.
    Oncogene; 1999 Mar 04; 18(9):1663-76. PubMed ID: 10208428
    [Abstract] [Full Text] [Related]

  • 4. Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells.
    Terada Y, Inoshita S, Nakashima O, Tamamori M, Ito H, Kuwahara M, Sasaki S, Marumo F.
    Kidney Int; 1999 Aug 04; 56(2):494-501. PubMed ID: 10432388
    [Abstract] [Full Text] [Related]

  • 5. Adenovirus-directed expression of dominant negative estrogen receptor induces apoptosis in breast cancer cells and regression of tumors in nude mice.
    Lee EJ, Jakacka M, Duan WR, Chien PY, Martinson F, Gehm BD, Jameson JL.
    Mol Med; 2001 Nov 04; 7(11):773-82. PubMed ID: 11788792
    [Abstract] [Full Text] [Related]

  • 6. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
    Han H, Nomura T, Honjo T, Tsubata T.
    Eur J Immunol; 1996 Oct 04; 26(10):2425-32. PubMed ID: 8898956
    [Abstract] [Full Text] [Related]

  • 7. Systemic gene therapy with p53 inhibits breast cancer: recent advances and therapeutic implications.
    Chen QR, Mixson AJ.
    Front Biosci; 1998 Sep 15; 3():D997-D1004. PubMed ID: 9740551
    [Abstract] [Full Text] [Related]

  • 8. Critical role for p27Kip1 in cell cycle arrest after androgen depletion in mouse mammary carcinoma cells (SC-3).
    Menjo M, Kaneko Y, Ogata E, Ikeda K, Nakanishi M.
    Oncogene; 1998 Nov 19; 17(20):2619-27. PubMed ID: 9840925
    [Abstract] [Full Text] [Related]

  • 9. Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells.
    Israyelyan AH, Melancon JM, Lomax LG, Sehgal I, Leuschner C, Kearney MT, Chouljenko VN, Baghian A, Kousoulas KG.
    Hum Gene Ther; 2007 May 19; 18(5):457-73. PubMed ID: 17536976
    [Abstract] [Full Text] [Related]

  • 10. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.
    Quintanilla-Martinez L, Thieblemont C, Fend F, Kumar S, Pinyol M, Campo E, Jaffe ES, Raffeld M.
    Am J Pathol; 1998 Jul 19; 153(1):175-82. PubMed ID: 9665478
    [Abstract] [Full Text] [Related]

  • 11. Dual targeting and enhanced cytotoxicity to HER2-overexpressing tumors by immunoapoptotin-armored mesenchymal stem cells.
    Cai Y, Xi Y, Cao Z, Xiang G, Ni Q, Zhang R, Chang J, Du X, Yang A, Yan B, Zhao J.
    Cancer Lett; 2016 Oct 10; 381(1):104-12. PubMed ID: 27473824
    [Abstract] [Full Text] [Related]

  • 12. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
    Gillett CE, Smith P, Peters G, Lu X, Barnes DM.
    J Pathol; 1999 Jan 10; 187(2):200-6. PubMed ID: 10365095
    [Abstract] [Full Text] [Related]

  • 13. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
    Li ZB, Zeng ZJ, Chen Q, Luo SQ, Hu WX.
    BMC Cancer; 2006 Mar 16; 6():66. PubMed ID: 16539746
    [Abstract] [Full Text] [Related]

  • 14. Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone Metastases.
    Yang Y, Xu W, Neill T, Hu Z, Wang CH, Xiao X, Stock SR, Guise T, Yun CO, Brendler CB, Iozzo RV, Seth P.
    Hum Gene Ther; 2015 Dec 16; 26(12):813-25. PubMed ID: 26467629
    [Abstract] [Full Text] [Related]

  • 15. Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor.
    Kwon TK, Nordin AA.
    Oncogene; 1998 Feb 12; 16(6):755-62. PubMed ID: 9488039
    [Abstract] [Full Text] [Related]

  • 16. Adenovirus expressing mutant p27kip1 enhanced apoptosis against cholangiocarcinoma than adenovirus-p27kip1 wild type.
    Sasaki T, Katayose Y, Suzuki M, Yamamoto K, Shiraso S, Mizuma M, Unno M, Takeuchi H, Lee CT, Matsuno S.
    Hepatogastroenterology; 2004 Feb 12; 51(55):68-75. PubMed ID: 15011833
    [Abstract] [Full Text] [Related]

  • 17. Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity.
    Palmer K, Hitt M, Emtage PC, Gyorffy S, Gauldie J.
    Gene Ther; 2001 Feb 12; 8(4):282-90. PubMed ID: 11313802
    [Abstract] [Full Text] [Related]

  • 18. Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer.
    Miceli C, Tejada A, Castaneda A, Mistry SJ.
    Cancer Gene Ther; 2013 May 12; 20(5):298-307. PubMed ID: 23618950
    [Abstract] [Full Text] [Related]

  • 19. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).
    St Croix B, Sheehan C, Rak JW, Flørenes VA, Slingerland JM, Kerbel RS.
    J Cell Biol; 1998 Jul 27; 142(2):557-71. PubMed ID: 9679152
    [Abstract] [Full Text] [Related]

  • 20. A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors.
    Hernandez-Alcoceba R, Pihalja M, Wicha MS, Clarke MF.
    Hum Gene Ther; 2000 Sep 20; 11(14):2009-24. PubMed ID: 11020800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.